ArticleThe Journal of biological chemistry2016

An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells.

Kévin Ly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.